Back to search

National and Kapodistrian University of Athens

Μελέτη της ανάπτυξης κοιλιοκάκης σε ασθενείς με HCV-ηπατοπάθεια που περιβάλλονται σε συνδυασμένη αγωγή με πεγκυλιωμένη ιντερφερόνη άλφα-2b και ριμπαβιρίνη

Abstract

dc:description

The aim of this dissertation was to study the onset of celiac disease, by the detection of serological markers of the disease (anti-ΕΜΑ-IgA, anti-GL-IgG and anti-GL-IgA) and by histological verification of celiac disease in patients with chronic hepatitis C under PEG-IFN-α2b plus ribavirin treatment. In this study 91 patients (64 men, 27 women) with chronic hepatitis C were included. All patients had never received in the past any treatment against HCV. We checked these patients for serological markers of celiac disease before treatment and we detected 9 patients being positive (9,9%). We also found that none of these 9 patients had histological lesions in the small bowel compatible with celiac disease. Initially, all 91 patients received PEG-IFN-α2b plus ribavirin. 12 patients stopped treatment for various reasons and were excluded from the study. Finally, 79 patients (57 men, 22 women) completed the six-month surveillance under PEG-IFN-α2b plus ribavirin treatment and were analyzed. In order to investigate for any difference between our study population and the general population of Greece, for the presence of anti-ΕΜΑ-IgA, anti-GL-IgG and anti-GL-IgA, we also included in our study 88 age-, sex- and BMI-matched blood donors as controls. Only two of them (2,3%) were positive for serological markers of celiac disease. Conclusions: a) the six-month PEG-IFN-α2b plus ribavirin treatment schedule for chronic hepatitis C does not induce the onset of celiac disease (clinically or serologically), b) chronic HCV infection positively correlates with the appearance of serological markers of celiac disease, without any clinical or histological evidence of the disease and c) serological markers of celiac disease should be included in the investigation of patients with chronic hepatitis C.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2006

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Fotos, Nikolaos
  • Φώτος, Νικόλαος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/20779

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Fotos, Nikolaos; Φώτος, Νικόλαος. Μελέτη της ανάπτυξης κοιλιοκάκης σε ασθενείς με HCV-ηπατοπάθεια που περιβάλλονται σε συνδυασμένη αγωγή με πεγκυλιωμένη ιντερφερόνη άλφα-2b και ριμπαβιρίνη. National and Kapodistrian University of Athens, 2006. http://hdl.handle.net/10442/hedi/20779